Cytarabine prevents neuronal damage by enhancing AMPK to stimulate PINK1 / Parkin-involved mitophagy in Parkinson's disease model
- 15 June 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 977, 176743
Abstract
No abstract availableKeywords
Funding Information
- Qingdao University (QDFYQN202101003)
- Natural Science Foundation of Shandong Province (ZR2023MH185)
- Natural Science Foundation of Qingdao Municipality (23-2-1-168-zyyd-jch)
This publication has 50 references indexed in Scilit:
- The neuroprotective effects of peracetylated chitosan oligosaccharides against β-amyloid-induced cognitive deficits in ratsMarine Life Science & Technology, 2023
- Mitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic StrategiesNeurochemical Research, 2023
- Impact of Oncology Drug Shortages on Chemotherapy TreatmentClinical Pharmacology & Therapeutics, 2019
- Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic PerspectivesMolecular Neurobiology, 2018
- The role of mitochondria in axon development and regenerationDevelopmental Neurobiology, 2017
- Basic Colorimetric Proliferation Assays: MTT, WST, and Resazurin2017
- Metformin improves anxiety-like behaviors through AMPK-dependent regulation of autophagy following transient forebrain ischemiaMetabolic Brain Disease, 2015
- Primary Neuron/Astrocyte Co‐Culture on Polyelectrolyte Multilayer Films: A Template for Studying Astrocyte‐Mediated Oxidative Stress in NeuronsAdvanced Functional Materials, 2008
- Tyrosine hydroxylase and Parkinson's diseaseMolecular Neurobiology, 1998
- YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viabilityJournal of Immunological Methods, 1995